Five-year intra-individual variability in C-reactive protein levels in a Japanese population-based study - The Jichi Medical School Cohort Study at Yamato, 1993-1998

Japanese Circulation Journal

Volumn 64, Issue 4, 2000, Pages 303-308

  Kayaba, Kazunori ^a,b   Ishikawa, Shizukiyo ^a   Gotoh, Tadao ^a   Nago, Naoki ^a   Kajii, Eiji ^a   Nakamura, Yosikazu ^a   Kario, Kazuomi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Yukiguni Yamato General Hospital   (Japan)

Author keywords

C reactive protein; Cardiovascular risk factors; Intraindividual variability; Population based study

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; INDIVIDUALIZATION; JAPAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBSERVER VARIATION; POPULATION RESEARCH; RISK FACTOR;

ADULT; AGED; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; JAPAN; MALE; MIDDLE AGED; TIME FACTORS; VARIATION (GENETICS);

EID: 0034086303     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.64.303     Document Type: Article

References (27)

1. Ross R: The pathogenesis of atherosclerosis: a perspective tor the 1990s. Nature 1993; 362: 801-809
2. Alexander RW: Inflammation and coronary artery disease [Editorial]. N Engl J Med 1994; 331: 468-469
3. Danesh J, Collins R, Appleby P, Peto R: Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA 1998; 279: 1477-1482
4. Liuzzo G, Biasucci LM. Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al: The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-424
5. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB, for European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group: Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997; 349: 462-466
6. Soeki T, Tamura Y, Shinohara H, Tanaka H, Bando K, Yui Y, et al: Fibrinolytic factors, serum lipid and C-reactive protein predicting cardiac events in Japanese patients with coronary atherosclerotic lesions. Jpn Circ J 1999; 63: 976-980
7. Kuller LH, Tracy RP, Shaten J, Meilahn EN for the MRFIT Research Group: Relation of C-reactive protein and coronary heart disease in the MRFIT: Nested case-control study. Am J Epidemiol 1996; 144: 537-547
8. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979
9. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, et al: Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997; 17: 1121-1127
10. Ridker PM, Glynn RJ, Hennekens CH: C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998; 97: 2007-2011
11. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731-733
12. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC: C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312: 1061-1065
13. Dogue B, Leppänen EA, Teppo AM, Fyhrquist F, Gräsbeck R: Effects of psychological stress on plasma interleukins-1l beta and 6, C-reactive protein, tumor necrosis factor alpha, anti-diuretic hormone and serum Cortisol. Scand J Clin Lab Invest 1993; 53: 555-561
14. Clark GH, Fraser CG: Biological variation of acute phase proteins. Ann Clin Biochem 1993; 30: 373-376
15. Macy EM, Hayes TE, Tracy RP: Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997; 43: 52-58
16. de Maat MPM, de Bart ACW, Meijer BC, Havelaar AC, Mulder PGH, Kluft C: Interindividual and intra-individual variability in plasma fibrinogen, TPA antigen. PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris. Arterioscler Thromb Vasc Biol 1996; 16: 1156-1162
17. Nago N, Kayaba K, Kario M, Tsutsumi A, Nakamura Y, Igarashi M, et al: Lipoprotein(a) levels in the Japanese population: influence of age and sex, and relation to atherosclerotic risk factors: The Jichi Medical School Cohort Study. Am J Epidemiol 1995; 141: 815-821
18. Gotoh T, Kuroda T, Nagoh N, Kayaba K, Yamada S, Shimada K, et al: Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). Am J Cardiol 1995; 76: 928-932
19. Kario K, Nago N, Kayaba K, Tsutsumi A, Ishikawa S, Shimada K, on behalf of the Jichi Medical School Cohort Study Group: Characteristics of the insulin resistance syndrome in a Japanese population: The Jichi Medical School Cohort Study. Arterioscler Thromb Vasc Biol 1996; 16: 269-274
20. Kayaba K, Nago N, Miyamoto T, Mizooka M, Nakamura Y, Igarashi M, et al: Glycated hemoglobin levels and their correlation with atherosclerotic risk factors in a Japanese population: the Jichi Medical School Cohort Study 1993-1995. Jpn Circ J 1998; 62: 261-266
21. Itoh Y, Ichihara K, Kanno T, Sugawara T, Ohkubo A, Kawai T, et al: Serum protein standardization project in Japan: Evaluation of an IFCC reference material (RPPHS/CRM470) and establishment of reference intervals. J Clin Lab Anal 1997; 11: 39-44
22. Meigs JB, Nathan DM, Cupples LA, Wilson PWF, Singer DE: Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study. J Clin Epidemiol 1996; 49: 411-417
23. Belanger A, Cupples L, D'Agostino R. Section 36; Means at each examination and inter-examination consistency of specified characteristics: Framingham Heart Study, 30-year follow-up. In: Kannel W, Wolf P, Garrison R, editors. The Framingham Study: An epidemiological investigation of cardiovascular disease. Washington, D.C.: US Department of Health and Human Services, 1988
24. Kujala UM, Kaprio J, Sama S, Koskenvuo M: Relationship of leisure-time physical activity and mortality: The Finnish Twin Cohort. JAMA 1998; 279: 440-444
25. Pyke SD, Thompson SG, Buchwalsky R, Kienast J: Variability over time of haemostatic and other cardiovascular risk factors in patients suffering from angina pectoris: ECAT Angina Pectoris Study Group. Thromb Haemost 1993; 70: 743-746
26. Iso H, Folsom AR, Wu KK, Finch A, Munger RG, Sato S, et al: Hemostatic variables in Japanese and Caucasian men: plasma fibrinogen, factor VIIc, and von Willebrand factor and their relations to cardiovascular disease factors. Am J Epidemiol 130: 925-934
27. Pickup JC, Mattock MB, Chusney GD, Burt D: NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40: 1286-1292